itraconazole has been researched along with Hematologic Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Imoto, Y; Kawakami, J; Miyadera, Y; Naito, T; Ono, T | 1 |
| Gan, SL; Liu, LX; Liu, YF; Ma, J; Sun, H; Sun, L; Wan, DM; Wu, FF; Xie, XS | 1 |
| Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
| Huang, XJ; Ji, Y | 1 |
| Chen, Y; Shen, ZX | 1 |
| Fu, R; Guan, J; Li, LJ; Liang, Y; Liu, CY; Liu, H; Qu, W; Ruan, EB; Shao, ZH; Song, J; Wang, GJ; Wang, HQ; Wang, J; Wang, XM; Wu, YH; Xing, LM | 1 |
| Kawano, K; Kobayashi, H; Nakagawa, S; Ohta, S; Shimoeda, S; Yamato, S | 1 |
| Egerer, G | 1 |
| Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E | 1 |
| Chen, QS; Shen, ZX | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Lu, J; Wang, JZ; Xu, LP; Zhang, YC | 1 |
| Berenguer Berenguer, J | 1 |
| Glasmacher, A; Just-Nübling, G; Molitor, E | 1 |
3 review(s) available for itraconazole and Hematologic Diseases
| Article | Year |
|---|---|
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis | 2004 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
[Therapy of invasive mycoses in neutropenic patients with hematologic system diseases].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Chemistry, Pharmaceutical; Fluconazole; Flucytosine; Hematologic Diseases; Humans; Itraconazole; Mycoses | 1998 |
10 other study(ies) available for itraconazole and Hematologic Diseases
| Article | Year |
|---|---|
Associations between plasma hydroxylated metabolite of itraconazole and serum creatinine in patients with a hematopoietic or immune-related disorder.
Topics: Administration, Oral; Aged; Antifungal Agents; Creatinine; Cystatin C; Female; Glomerular Filtration Rate; Hematologic Diseases; Humans; Hydroxylation; Immune System Diseases; Itraconazole; Male; Middle Aged | 2021 |
[The clinical study of invasive fungal infection in 76 cases of hematologic diseases].
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Female; Hematologic Diseases; Humans; Itraconazole; Male; Middle Aged; Mycoses; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2013 |
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult | 2016 |
[A retrospective study of efficacy and safety of itraconazole for treatment of invasive fungal infection in hematologic diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Male; Middle Aged; Mycoses; Retrospective Studies | 2008 |
[Sequential intravenous and oral itraconazole in treatment of invasive fungal infection in hematological diseases].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Diseases; Humans; Injections, Intravenous; Itraconazole; Male; Middle Aged; Mycoses | 2008 |
[An analysis of efficacy and related factors of itraconazole in the treatment of invasive fungal infection in hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Female; Hematologic Diseases; Humans; Itraconazole; Male; Middle Aged; Mycoses; Retrospective Studies; Young Adult | 2010 |
Clinical significance of measuring the blood concentration of itraconazole oral solution in the field of hematology.
Topics: Aged; Antifungal Agents; Chromatography, High Pressure Liquid; Creatinine; Female; Hematologic Diseases; Hematology; Humans; Itraconazole; Male; Middle Aged; Mycoses; Neutropenia; Sex Factors; Solutions | 2010 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
[Clinical manifestation and treatment of blood disease combined with invasive fungal infection].
Topics: Antifungal Agents; Candidiasis; Female; Hematologic Diseases; Humans; Itraconazole; Male; Mycoses | 2005 |
[Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis; Child; Female; Hematologic Diseases; Humans; Immunocompromised Host; Injections, Intravenous; Itraconazole; Male; Middle Aged; Mycoses; Treatment Outcome | 2005 |